Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Design Therapeutics, Inc. Common Stock, par value $0.0001 per share (DSGN).
- Disclosed ownership: 5.2%.
- Date of event: 27 Aug 2025.
Point72 Asset Management, L.P. - 27 Aug 2025 SCHEDULE 13G Report for Design Therapeutics, Inc. Common Stock, par value $0.0001 per share (DSGN)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- DSGN
- Shares outstanding
- 56,590,750 shares
- Disclosed Ownership
- 2,942,719 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 28 Aug 2025, 16:05:12 UTC
- Date of event
- 27 Aug 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5.2% ownership in Design Therapeutics, Inc. Common Stock, par value $0.0001 per share (DSGN) on 27 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5.2% | 2,942,719 | 0 | 2,942,719 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5.2% | 2,942,719 | 0 | 2,942,719 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.2% | 2,942,719 | 0 | 2,942,719 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |